Mats Wahlstrom
Mats Wahlstrom's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link…
Insider buying and selling since 2015
Mats Wahlstrom bought shares on the open market in 2024 and 2026 across 2 companies. Sales in 4 of the 12 years since 2015.
Mats Wahlstrom reported 4 open-market purchases and 10 sales since 2015; purchases in 2 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2025 | — | 1×1 trade |
| 2024 | 3×3 trades | — |
| 2020 | — | 3×3 trades |
| 2016 | — | 2×2 trades |
| 2015 | — | 4×4 trades |
Insider at 2 companies
- Trisalus Life Sciences TLSI2024–2026 · 4 purchases, 0 sales
- Coherus Oncology CHRS2015–2025 · 0 purchases, 10 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Mats Wahlstrom's trades
Has Mats Wahlstrom bought shares on the open market?
Mats Wahlstrom bought shares on the open market in 2024 and 2026 across 2 companies. Sales in 4 of the 12 years since 2015.
When did Mats Wahlstrom last buy or sell shares?
In SEC filings since 2015: the latest open-market purchase is from 2026; the latest open-market sale is from 2025.
Which companies has Mats Wahlstrom traded as an insider?
2 companies: Trisalus Life Sciences (TLSI, 2024–2026), Coherus Oncology (CHRS, 2015–2025).